Biopolym. Cell. 2000; 16(2):99-107.
http://dx.doi.org/10.7124/bc.00055C
Огляди
Структура та біологічні властивості пластівцевоутворюючого фактора золотистого стафілокока
1Іванова В. Д., 1Позур В. К.
  1. Київський національний університет імені Тараса Шевченка
    вул. Володимирська 64, Київ, Україна, 01033

Abstract

Пластівцевоутворюючий фактор – один із компонентів клітинної стінки Staphylococcus aureus – глікопротеїн, молекулярна маса якого складає 92 кДа. Фактор обумовлює плазмоаглютинацію, відіграє важливу роль в адгезії мікробних клітин до клітин організму, перешкоджає ефективному фагоцитозу бактерій, може викликати агрегацію тромбоцитів. Очищений фактор у суміші з ад'ювантом Фрейнда, а також у складі мікробної клітини призводить до появи специфічних антитіл в імунізованих тварин, здатний активувати комплемент in vitro.
Повний текст: (PDF, українською)

References

[1] Foster TJ, McDevitt D. Surface-associated proteins of Staphylococcus aureus: their possible roles in virulence. FEMS Microbiol Lett. 1994;118(3):199-205.
[2] Immunology of infection. Eds. V. I. Pokrovskiy, S. P. Gordienko. M., 1994. 306 p.
[3] Bacteriology 330 lecture topics: Staphilococcus. Madison: Kenneth Todor Univ. press, 1998.
[4] Tenover FC, Arbeit R, Archer G, Biddle J, Byrne S, Goering R, Hancock G, H?bert GA, Hill B, Hollis R, et al. Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus. J Clin Microbiol. 1994;32(2):407-15.
[5] Freney J, Kloos WE, Hajek V, Webster JA, Bes M, Brun Y, Vernozy-Rozand C. Recommended minimal standards for description of new staphylococcal species. Subcommittee on the taxonomy of staphylococci and streptococci of the International Committee on Systematic Bacteriology. Int J Syst Bacteriol. 1999;49 Pt 2:489-502.
[6] Croize J, Gialanella P, Monnet D, Okada J, Orsi A, Voss A, Merlin S. Improved identification of Staphylococcus aureus using a new agglutination test. Results of an international study. APMIS. 1993;101(6):487-91.
[7] Kochman M, Lawrynowicz M, Fordymacki P, Ka?uzewski S. Evaluation of external laboratory test results for the correct identification and determination of chemotherapeutic sensitivity of staphylococci in bacteriologic provincial laboratories of sanitary-epidemiologic stations in 1995. Med Dosw Mikrobiol. 1996;48(3-4):131-40.
[8] Luijendijk A, van Belkum A, Verbrugh H, Kluytmans J. Comparison of five tests for identification of Staphylococcus aureus from clinical samples. J Clin Microbiol. 1996;34(9):2267-9.
[9] Cooke RP, Jenkins CT. Comparison of commercial slide agglutination kits with a tube coagulase test for the rapid identification of Staphylococcus aureus from blood culture. J Clin Pathol. 1997;50(2):164-6.
[10] Personne P, Bes M, Lina G, Vandenesch F, Brun Y, Etienne J. Comparative performances of six agglutination kits assessed by using typical and atypical strains of Staphylococcus aureus. J Clin Microbiol. 1997;35(5):1138-40.
[11] Ros MJ, Ram?rez A, Arteaga E, Alberto C, Gil J, Reina J. Infection by Staphylococcus lugdunensis: clinico-microbiologic characterization of 25 cases. Enferm Infecc Microbiol Clin. 1999;17(5):223-6.
[12] Nilsson M, Frykberg L, Flock JI, Pei L, Lindberg M, Guss B. A fibrinogen-binding protein of Staphylococcus epidermidis. Infect Immun. 1998;66(6):2666-73.
[13] Kuusela P, Hild?n P, Savolainen K, Vuento M, Lyytik?inen O, Vuopio-Varkila J. Rapid detection of methicillin-resistant Staphylococcus aureus strains not identified by slide agglutination tests. J Clin Microbiol. 1994;32(1):143-7.
[14] Br?ckler J, Berlich U, Schaeg W, Blobel H. Clumping-factor-reactions of Staphylococcus aureus of different origin in plasma- and fibrinogen-preparations(author's transl). Zentralbl Bakteriol Mikrobiol Hyg A. 1981;251(1):27-32.
[15] Usui Y. Biochemical properties of fibrinogen binding protein (clumping factor) of the staphylococcal cell surface. Zentralbl Bakteriol Mikrobiol Hyg A. 1986;262(3):287-97.
[16] Rocha CL, Fischetti VA. Identification and characterization of a new protein from Streptococcus pyogenes having homology with fibronectin and fibrinogen binding proteins. Adv Exp Med Biol. 1997;418:737-9.
[17] McDevitt D, Vaudaux P, Foster TJ. Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor. Infect Immun. 1992;60(4):1514-23.
[18] Dickinson RB, Nagel JA, McDevitt D, Foster TJ, Proctor RA, Cooper SL. Quantitative comparison of clumping factor- and coagulase-mediated Staphylococcus aureus adhesion to surface-bound fibrinogen under flow. Infect Immun. 1995;63(8):3143-50.
[19] Rupp ME, Archer GL. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis. 1994;19(2):231-43.
[20] Vandenesch F, Lebeau C, Bes M, McDevitt D, Greenland T, Novick RP, Etienne J. Coagulase deficiency in clinical isolates of Staphylococcus aureus involves both transcriptional and post-transcriptional defects. J Med Microbiol. 1994;40(5):344-9.
[21] M?ynarczyk G, Kochman M, Lawrynowicz M, Fordymacki P, M?ynarczyk A, Jeljaszewicz J. Selected properties of Staphylococcus aureus strains using phenotype to show a lack of coagulase synthesis. Med Dosw Mikrobiol. 1997;49(1-2):5-12.
[22] Wolz C, McDevitt D, Foster TJ, Cheung AL. Influence of agr on fibrinogen binding in Staphylococcus aureus Newman. Infect Immun. 1996;64(8):3142-7.
[23] Espersen F, Clemmensen I, Barkholt V. Isolation of Staphylococcus aureus clumping factor. Infect Immun. 1985;49(3):700-8.
[24] McDevitt D, Francois P, Vaudaux P, Foster TJ. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol. 1994;11(2):237-48.
[25] McDevitt D, Francois P, Vaudaux P, Foster TJ. Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol Microbiol. 1995;16(5):895-907.
[26] Foster T, McDevitt D. Molecular basis of adherence of staphylococci to biomaterials. Infections associated with indwelling medical devices. Eds A. L Bisno, F. A. Wald-vogel. Washington: Amer. Soc. Microbiol, publ., 1994.
[27] O'Connell DP, Nanavaty T, McDevitt D, Gurusiddappa S, H??k M, Foster TJ. The fibrinogen-binding MSCRAMM (clumping factor) of Staphylococcus aureus has a Ca2+-dependent inhibitory site. J Biol Chem. 1998;273(12):6821-9.
[28] Hartford O, Francois P, Vaudaux P, Foster TJ. The dipeptide repeat region of the fibrinogen-binding protein (clumping factor) is required for functional expression of the fibrinogen-binding domain on the Staphylococcus aureus cell surface. Mol Microbiol. 1997;25(6):1065-76.
[29] McDevitt D, Foster TJ. Variation in the size of the repeat region of the fibrinogen receptor (clumping factor) of Staphylococcus aureus strains. Microbiology. 1995;141 ( Pt 4):937-43.
[30] N? Eidhin D, Perkins S, Francois P, Vaudaux P, H??k M, Foster TJ. Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol. 1998;30(2):245-57.
[31] McDevitt D, Nanavaty T, House-Pompeo K, Bell E, Turner N, McIntire L, Foster T, H??k M. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. Eur J Biochem. 1997;247(1):416-24.
[32] Hawiger J, Kloczewiak M, Timmons S, Strong D, Doolittle RF. Interaction of fibrinogen with staphylococcal clumping factor and with platelets. Ann N Y Acad Sci. 1983;408:521-35.
[33] Bayer AS, Sullam PM, Ramos M, Li C, Cheung AL, Yeaman MR. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect Immun. 1995;63(9):3634-41.
[34] Vaudaux PE, Monzillo V, Francois P, Lew DP, Foster TJ, Berger-B?chi B. Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in vitro functional activities of fibrinogen and fibronectin adhesins. Antimicrob Agents Chemother. 1998;42(3):564-70.
[35] Nicholas RO, Li T, McDevitt D, Marra A, Sucoloski S, Demarsh PL, Gentry DR. Isolation and characterization of a sigB deletion mutant of Staphylococcus aureus. Infect Immun. 1999;67(7):3667-9.
[36] Cheung AL, Chien YT, Bayer AS. Hyperproduction of alpha-hemolysin in a sigB mutant is associated with elevated SarA expression in Staphylococcus aureus. Infect Immun. 1999;67(3):1331-7.
[37] Maianski? AN, Prisada TV, Nevmiatullin AL, van Zwieten R, Roos D. An opsonin-independent strain of Staphylococcus epidermidis. Zh Mikrobiol Epidemiol Immunobiol. 1997;(6):6-10.
[38] Dominiecki ME, Weiss J. Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus. Infect Immun. 1999;67(5):2299-305.
[39] Sawai T, Tomono K, Yanagihara K, Yamamoto Y, Kaku M, Hirakata Y, Koga H, Tashiro T, Kohno S. Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect Immun. 1997;65(2):466-71.
[40] Moreillon P, Entenza JM, Francioli P, McDevitt D, Foster TJ, Fran?ois P, Vaudaux P. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun. 1995;63(12):4738-43.
[41] Espersen F. Interactions between human plasma proteins and cell wall components of Staphylococcus aureus. Dan Med Bull. 1987;34(2):59-69.
[42] Mempel M, Schmidt T, Weidinger S, Schnopp C, Foster T, Ring J, Abeck D. Role of Staphylococcus aureus surface-associated proteins in the attachment to cultured HaCaT keratinocytes in a new adhesion assay. J Invest Dermatol. 1998;111(3):452-6.
[43] Espersen F, Clemmensen I. Immunization of mice with the fibronectin-binding protein and clumping factor from Staphylococcus aureus: antibody response and resistance against intraperitoneal infection. Acta Pathol Microbiol Immunol Scand C. 1985;93(2):53-8.
[44] Espersen F. Complement activation by clumping factor and protein A from Staphylococcus aureus strain E 2371. Acta Pathol Microbiol Immunol Scand C. 1985;93(2):59-64.